News
12/2012
11/2012
08/2012
Raved, Magriso, Benkel & Co., headed by Adv. Nir Oren, acted as Israeli counsel for Rosetta Genomics Ltd., a leading developer and provider of microRNA-based molecular diagnostics, in its underwritten public offering of 5.5 million shares in consideration for a gross amount of approximately 27.5 million US Dollars Read More »
08/2012
Raved, Magriso, Benkel & Co., headed by Adv. Einat Weidberg and Adv. Omer Tzur, acted as Israeli counsel for Reglera LLC (and its Israeli subsidiary), a leading provider of quality assurance and regulatory affairs consulting services to the medical device and human cellular tissue industries, in connection with the acquisition of Reglera LLC by the F. Dohmen Co. (Dohmen Company), one of the top ten pharmaceutical wholesalers in the United States. Read More »
07/2012
06/2012
Adv. Joseph Benkel was interviewed by Globes magazine with respect to the conduct of the Israeli State Attorney in connection with the criminal charges against Mr. Dani Danker, former chairman of Bank Hapoalim, and the use by the Israeli State Attorney of the suspects' attorneys in order to create shortcuts in the investigation and evidence collection procedure. Read More »
05/2012
05/2012
05/2012
Raved, Magriso, Benkel & Co., headed by Adv. Nir Oren, acted as Israeli counsel for Rosetta Genomics Ltd., a leading developer and provider of microRNA-based molecular diagnostics, in three registered direct offerings, for an aggregate gross consideration of approximately 10 million US Dollars. Read More »
04/2012
Raved, Magriso, Benkel & Co., headed by Adv. Joseph Benkel, Adv. Shmuel Galinka and Adv. Inbal Raz, represents David Lubinski, the Israeli importer of Peugeot and Citroen, in an appeal before the Israeli Supreme Court in connection with the results of the governmental commercial vehicles tender of the State of Israel Read More »

